Loading organizations...
sovaSage provides a digital healthcare platform that optimizes positive airway pressure (PAP) therapy for sleep apnea and chronic conditions. Its TherapistAssist™ software uses artificial intelligence for automated therapy management, augmented by human clinical oversight. This technology streamlines respiratory care, enhancing provider efficiency and improving patient treatment effectiveness.
Founded in 2020 by William Kaigler (CEO), Christian Kebekus (CTO), and Julie Kaigler (COO), sovaSage emerged from the founders' insight that traditional sleep apnea care lacked continuous, proactive support. Their combined expertise led to a solution blending advanced technology with essential clinical application.
sovaSage serves Home Medical Equipment providers, physicians, health systems, and sleep labs, facilitating improved patient population management. The company envisions redefining PAP therapy by offering continuous, proactive support tailored to individual communication preferences. This approach transforms chronic care, ensuring personalized treatment journeys and better adherence.
sovaSage has raised $50K across 1 funding round.
sovaSage has raised $50K in total across 1 funding round.
sovaSage is a digital health technology company specializing in AI-powered SaaS solutions for patient management in sleep apnea therapy, particularly improving CPAP (Continuous Positive Airway Pressure) adherence.[1][2][4] It builds products like sovaFit™ (AI mask fitting), sovaStart™ (onboarding automation), and sovaGuide™ with Jeanie™ (AI coaching), serving sleep labs, providers, and DME (Durable Medical Equipment) companies to solve low patient compliance, mask failures, and inefficient workflows—delivering outcomes like 4x fewer mask exchanges, >80% long-term adherence, and >800% ROI.[1][4][5]
The platform uses computer vision, machine learning, real-time analytics, and predictive engagement to guide patients from mask selection to sustained therapy success, empowering providers with data-driven insights while streamlining operations without added staff.[1][2][3][4]
Founded by William Kaigler, an entrepreneur-in-residence at Carnegie Mellon University’s Tepper School of Business with early career roots at Pittsburgh medical supply firm Respironics, sovaSage emerged to address stagnant innovation in sleep apnea treatment, unchanged for 30 years.[2][3] Co-founder Christian Kebekus serves as CTO, leading a team of engineers, clinicians, and entrepreneurs with nearly 100 years of collective sleep industry experience.[3][5]
The idea stemmed from unmet needs in obstructive sleep apnea care, fueled by advances in machine learning, AI, and computer vision to create the first major platform innovation since 1990.[3] Early traction built through partnerships like UPMC Enterprises (investor and development partner) and Parachute Health (for seamless mask fitting data transfer), evolving from a startup to an enterprise-grade SaaS provider with a 2025 rebrand emphasizing "Guided by Data. Driven by Care."[1][5]
sovaSage rides the wave of AI in digital health, targeting the $50B+ sleep apnea market where ~50% of CPAP patients abandon therapy due to poor fit and engagement—timing amplified by post-pandemic telehealth growth and AI advancements enabling remote, precise care.[1][2][3] Market forces like rising OSA prevalence (affecting 1B+ globally), provider staffing shortages, and demand for value-based care favor its data-driven model, which turns compliance into revenue via resupply boosts.[4]
It influences the ecosystem by setting standards for AI-PAP integration, partnering with health systems like UPMC to scale adoption, and disrupting a 30-year status quo with tools that blend tech innovation and clinical wisdom for better patient/provider outcomes.[3][5]
sovaSage is poised to dominate CPAP adherence with expanding AI capabilities, potentially integrating multimodal data (e.g., wearables) amid trends like personalized medicine and regulatory pushes for digital therapeutics. Expect deeper enterprise penetration, more partnerships, and global scaling as AI maturity grows, evolving from disruptor to indispensable platform—guided by data, driven by care, transforming sleep health economics.[1][4] This positions it as a high-momentum player in medtech's AI frontier, building on rebrand momentum for sustained growth.
sovaSage has raised $50K in total across 1 funding round.
sovaSage's investors include Animo Ventures, FJ Labs, Innovation Works, Tribeca Venture Partners, Ulu Ventures, Roger Ehrenberg.
sovaSage has raised $50K across 1 funding round. Most recently, it raised $50K Seed in January 2021.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jan 1, 2021 | $50K Seed | Animo Ventures, FJ Labs, Innovation Works, Tribeca Venture Partners, Ulu Ventures, Roger Ehrenberg |